» Articles » PMID: 32397189

Pathway Analysis of Genes Identified Through Post-GWAS to Underpin Prostate Cancer Aetiology

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2020 May 14
PMID 32397189
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding the functional role of risk regions identified by genome-wide association studies (GWAS) has made considerable recent progress and is referred to as the post-GWAS era. Annotation of functional variants to the genes, including or and understanding their biological pathway/gene network enrichments, is expected to give rich dividends by elucidating the mechanisms underlying prostate cancer. To this aim, we compiled and analysed currently available post-GWAS data that is validated through further studies in prostate cancer, to investigate molecular biological pathways enriched for assigned functional genes. In total, about 100 canonical pathways were significantly, at false discovery rate (FDR)< 0.05), enriched in assigned genes using different algorithms. The results have highlighted some well-known cancer signalling pathways, antigen presentation processes and enrichment in cell growth and development gene networks, suggesting risk loci may exert their functional effect on prostate cancer by acting through multiple gene sets and pathways. Additional upstream analysis of the involved genes identified critical transcription factors such as HDAC1 and STAT5A. We also investigated the common genes between post-GWAS and three well-annotated gene expression datasets to endeavour to uncover the main genes involved in prostate cancer development/progression. Post-GWAS generated knowledge of gene networks and pathways, although continuously evolving, if analysed further and targeted appropriately, will have an important impact on clinical management of the disease.

Citing Articles

Lineage Plasticity and Stemness Phenotypes in Prostate Cancer: Harnessing the Power of Integrated "Omics" Approaches to Explore Measurable Metrics.

Logotheti S, Papadaki E, Zolota V, Logothetis C, Vrahatis A, Soundararajan R Cancers (Basel). 2023; 15(17).

PMID: 37686633 PMC: 10486655. DOI: 10.3390/cancers15174357.


Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications.

Brandao A, Paulo P, Teixeira M Int J Mol Sci. 2020; 21(14).

PMID: 32708810 PMC: 7404100. DOI: 10.3390/ijms21145036.

References
1.
Mucci L, Hjelmborg J, Harris J, Czene K, Havelick D, Scheike T . Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. JAMA. 2016; 315(1):68-76. PMC: 5498110. DOI: 10.1001/jama.2015.17703. View

2.
Ferris-I-Tortajada J, Berbel-Tornero O, Garcia-I-Castell J, Lopez-Andreu J, Sobrino-Najul E, Ortega-Garcia J . [Non dietetic environmental risk factors in prostate cancer]. Actas Urol Esp. 2011; 35(5):289-95. PMC: 5176024. DOI: 10.1016/j.acuro.2010.12.010. View

3.
Marzec J, Mao X, Li M, Wang M, Feng N, Gou X . A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population. Oncotarget. 2016; 7(16):21393-403. PMC: 5008293. DOI: 10.18632/oncotarget.7250. View

4.
Leong K, Gao W . The Notch pathway in prostate development and cancer. Differentiation. 2008; 76(6):699-716. DOI: 10.1111/j.1432-0436.2008.00288.x. View

5.
Cowen L, Ideker T, Raphael B, Sharan R . Network propagation: a universal amplifier of genetic associations. Nat Rev Genet. 2017; 18(9):551-562. DOI: 10.1038/nrg.2017.38. View